Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

PODD stock hub

Insulet Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PODDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.7B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PODD

In the news

Latest news · PODD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.2

P25 12.3P50 18.4P75 33.1

Trailing P/E35.9

P25 14.9P50 23.2P75 38.5

ROE23

P25 -105.6P50 -46.5P75 -3.1

ROIC20.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PODD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

267

Groups with data

Currency

USD

Showing 267 of 267 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001145197
Company name	Insulet Corporation
Country	United States
Country code	US
Cusip	45784P101
Employees	5,400
Employees Change	1,500%
Employees Change Percent	38.46
Enterprise value	$11.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Devices
IPO Date	2007-05-15
Isin	US45784P1012
Last refreshed	2026-05-10
Market cap	$10.7B
Market cap category	Large-Cap
Price	$154
Price currency	USD
Rev Per Employee	537,185.19x
Sector	Healthcare
Sic	3841
Symbol	PODD
Website	https://www.insulet.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.84%
EV Earnings	37.03x
EV Sales Forward	3.2x
EV/EBIT	22.11x
EV/EBITDA	18.62x
EV/FCF	26.97x
EV/Sales	3.86x
FCF yield	3.89%
Forward P/E	23.18x
P/B ratio	8.2x
P/E ratio	35.94x
P/S ratio	3.68x
PE Ratio10 Y	2,027.35x
PE Ratio3 Y	84.39x
PE Ratio5 Y	2,517.56x
PEG ratio	1.16x
PS Forward	3.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.48%
EBITDA Margin	20.75%
FCF margin	14.33%
Gross margin	71.01%
Gross Profit	$2.1B
Gross Profit Growth	33.06%
Gross Profit Growth Q	29.31%
Gross Profit Growth3 Y	32.06%
Gross Profit Growth5 Y	27.02%
Net Income	$302.8M
Net Income Growth	-24.71%
Net Income Growth Q	157.35%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	696.16%
Net Income Growth5 Y	102.47%
Pretax Margin	13.94%
Profit Margin	10.44%
Profit Per Employee	$56,074
Profitable Years	8
ROA	9.75
Roa5y	5.52
ROCE	22.05
ROE	23
Roe5y	19.81
ROIC	20.87
Roic5y	13.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.88%
Cagr15y	14.37%
Cagr1y	-41.7%
Cagr3y	-22.31%
Cagr5y	-8.02%
EPS Growth	-22.69
EPS Growth Q	159
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	691.9
EPS Growth5 Y	102.2
FCF Growth	42.71%
FCF Growth Q	73.79%
FCF Growth3 Y	220.73%
OCF Growth	52.39%
OCF Growth Q	78.37%
OCF Growth3 Y	66.9%
OCF Growth5 Y	63.81%
Revenue Growth	31.92x
Revenue Growth Q	33.87x
Revenue Growth Quarters	42x
Revenue Growth Years	11x
Revenue Growth3 Y	28.47x
Revenue Growth5 Y	24.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.89
Assets	$3B
Cash	$480.4M
Current Assets	$1.7B
Current Liabilities	$687.5M
Debt	$1B
Debt EBITDA	$1.65
Debt Equity	$0.78
Debt FCF	$2.44
Equity	$1.3B
Interest Coverage	7.81
Liabilities	$1.7B
Long Term Assets	$1.3B
Long Term Liabilities	$997.1M
Net Cash	$-533.6M
Net Cash By Market Cap	$-5
Net Debt EBITDA	$0.89
Net Debt Equity	$0.41
Net Debt FCF	$1.28
Tangible Book Value	$1.1B
Tangible Book Value Per Share	$16.4
WACC	10.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.49
Inventory Turnover	1.86
Net Working Capital	$560.2M
Quick ratio	1.49
Working Capital	$1B
Working Capital Turnover	$2.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.15%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	417.84%
1Y total return	-41.67%
200-day SMA	279
3Y total return	-53.11%
50-day SMA	207.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-34.17%
All Time High	354.9
All Time High Change	-56.56%
All Time High Date	2025-11-20
All Time Low	2.57
All Time Low Change	5,898.44%
All Time Low Date	2009-03-09
ATR	8.8
Beta	1.2
Beta1y	0.49
Beta2y	0.67
Ch YTD	-45.76
High	164.7
High52	354.9
High52 Date	2025-11-20
High52ch	-56.56%
Low	154
Low52	148.3
Low52 Date	2026-05-06
Low52ch	3.95%
Ma50ch	-25.58%
Premarket Change Percent	-0.84
Premarket Price	$159
Price vs 200-day SMA	-44.74%
RSI	28.86
RSI Monthly	34.92
RSI Weekly	18.39
Sharpe ratio	-1.19x
Sortino ratio	-1.57
Total Return	4.15%
Tr YTD	-45.76
Tr15y	649.81%
Tr1m	-23.86%
Tr1w	-11.93%
Tr3m	-36.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	21
Analyst Count Top	1
Analyst Price Target Top	$350
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$1.18
Earnings EPS Estimate Growth	15.69
Earnings Revenue Estimate	729,718,672x
Earnings Revenue Estimate Growth	28.25x
Operating Income	$507.1M
Operating Income Growth	48.8
Operating Income Growth Q	37.5
Operating Income Growth3 Y	81.15
Operating Income Growth5 Y	53.09
Operating margin	17.48
Price target	$290
Price Target Change	$88.24
Price Target Change Top	$127

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	68,973,508%
Float Percent	99.58%
Net Borrowing	-986,100,000
Shares Insiders	0.29%
Shares Institutions	100.46%
Shares Out	69,264,674
Shares Qo Q	-0.66%
Shares Yo Y	-4.16%
Short Float	3.92%
Short Ratio	3.1
Short Shares	3.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$349.9M
Average Volume	1,459,340.9x
Bv Per Share	18.81
CAPEX	$-203.6M
Ch10y	417.8
Ch15y	649.8
Ch1m	-23.86
Ch1w	-11.93
Ch1y	-41.67
Ch3m	-36.28
Ch3y	-53.11
Ch5y	-34.17
Ch6m	-51.8
Change	-3.89%
Change From Open	-4.57
Close	160.4
Days Gap	0.72
Depreciation Amortization	94,900,000
Dollar Volume	267,818,930.6
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$507.1M
EBITDA	$602M
EPS	$4.29
F Score	7
FCF	$415.7M
FCF EV Yield	3.71x
FCF Per Share	$6
Financing CF	-1,192,900,000
Fiscal Year End	December
Founded	2,000
Goodwill	51,600,000
Graham Number	42.60366
Graham Upside	-72.36
Income Tax	$101.6M
Investing CF	-234,800,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-18
Lynch Fair Value	$107
Lynch Upside	-30.44
Ma150	265.3
Ma150ch	-41.9%
Ma20	182.9
Ma20ch	-15.73%
Net CF	-802,700,000
Next Earnings Date	2026-08-06
Open	161.6
Optionable	Yes
P FCF Ratio	25.69
P OCF Ratio	17.24
Position In Range	1.5
Post Close	154.2
Postmarket Change Percent	3.19
Postmarket Price	$159
Ppne	830,400,000
Pre Close	160.4
Price Date	2026-05-08
Price EBITDA	$17.74
Ptbv Ratio	9.4
Relative Volume	1.19x
Revenue	2,900,800,000x
SBC By Revenue	2.27x
Share Based Comp	65,800,000
Tax By Revenue	3.5x
Tax Rate	25.12%
Tr6m	-51.8%
Us State	Massachusetts
Volume	1,737,279
Z Score	9.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PODD pay a dividend?

Capital-return profile for this ticker.

Performance

PODD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PODD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+100.5%

Float: +99.6% of shares outstanding

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PODD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.9

Below 30: short-term oversold

Price vs 200-day MA

-44.7%

50/200-day relationship not available

Beta (5Y)

1.20

Moves roughly with the market

Sharpe ratio

-1.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PODD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PODD stock rating?

Insulet Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PODD analysis?

The full report lives at /stocks/PODD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PODD?

The latest report frames PODD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PODD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.